Inositol 1,4,5-trisphosphate receptor degradation pathways

Wiley Interdisciplinary Reviews: Membrane Transport and Signaling

Volumn 1, Issue 2, 2012, Pages 126-135

  Wojcikiewicz, Richard J H ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CASPASE 3; ERLIN1 PROTEIN; ERLIN2 PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; LYSINE; MEMBRANE PROTEIN; PROTEASOME; RING FINGER PROTEIN; RING FINGER PROTEIN 170; UNCLASSIFIED DRUG;

BINDING AFFINITY; BINDING SITE; CELL MIGRATION; ENZYME ACTIVITY; LYSOSOME; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RESIDUE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84879192771     PISSN: 2190460X     EISSN: 21904618     Source Type: Journal    
DOI: 10.1002/wmts.4     Document Type: Review

References (63)

1. 3 receptors: the search for structure. Trends Biochem Sci 2004, 29:210-219.
2. 2+ release channels. Physiol Rev 2007, 87:593-658.
3. 2+ channel: from discovery to new signaling concepts. J Neurochem 2007, 102:1426-1446.
4. 2+ channels on the move. Biochemistry 2009, 48:12062-12080.
5. 3 receptor-mitochondria connection in apoptosis and autophagy. Biochim Biophys Acta 2011, 1813:1003-1013.
6. Schug ZT, Joseph SK. The role of the S4-S5 linker and C-terminal tail in inositol 1, 4, 5-trisphosphate receptor function. J Biol Chem 2006, 281:24431-24440.
7. Schug ZT, da Fonseca PC, Bhanumathy CD, Wagner L II, Zhang X, Bailey B, Morris EP, Yule DI, Joseph SK. Molecular characterization of the inositol 1, 4, 5-trisphosphate receptor pore-forming segment. J Biol Chem 2008, 283:2939-2948.
8. Pantazaka E, Taylor CW. Targeting of inositol 1, 4, 5-trisphosphate receptor to the endoplasmic reticulum by its first transmembrane domain. Biochem J 2010, 425:61-69.
9. Parker AKT, Gergely FV, Taylor CW. Targeting of inositol 1, 4, 5-trisphosphate receptors to the endoplasmic reticulum by multiple signals within their transmembrane domains. J Biol Chem 2004, 279: 23797-23805.
10. Galvan DL, Mignery GA. Carboxyl-terminal sequences critical for inositol 1, 4, 5-trisphosphate receptor subunit assembly. J Biol Chem 2002, 277:48248-48260.
11. Taylor CW, Genazzani AA, Morris SA. Expression of inositol 1, 4, 5-trisphosphate receptors. Cell Calcium 1999, 26:237-251.
12. Joseph SK. Biosynthesis of the inositol 1, 4, 5-trisphosphate receptor in WB rat liver epithelial cells. J Biol Chem 1994, 269:5673-5679.
13. Wojcikiewicz RJH, Furuichi T, Nakade S, Mikoshiba K, Nahorski SR. Muscarinic receptor activation down-regulates the type I inositol 1, 4, 5-trisphosphate receptor by accelerating its degradation. J Biol Chem 1994, 269:7963-7969.
14. Wojcikiewicz RJH. Type I, II and III inositol 1, 4, 5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem 1995, 270:11678-11683.
15. Kahn MT, Joseph SK. Proteolysis of type I inositol 1, 4, 5-trisphosphate receptor in WB rat liver cells. Biochem J 2003, 375:603-611.
16. Mohler PJ, Davis JQ, Davis LH, Hoffman JA, Michaely P, Bennett V. Inositol 1, 4, 5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B. J Biol Chem 2004, 279:12980-12987.
17. Wojcikiewicz RJH, Nahorski SR. Chronic muscarinic stimulation of SH-SY5Y neuroblastoma cells suppresses inositol 1, 4, 5-trisphosphate action: parallel inhibition of inositol 1, 4, 5-trisphosphate-induced Ca2+ mobilization and inositol 1, 4, 5-trisphosphate binding. J Biol Chem 1991, 266:22234-22241.
18. 3 receptors and the ERAD pathway. Cell Calcium 2009, 46:147-153.
19. Bokkala S, Joseph SK. Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells: evidence for the involvement of the proteasome pathway. J Biol Chem 1997, 272:12454-12461.
20. 3-activated elementary calcium signals and are downregulated by prolonged hormonal stimulation to inhibit cellular calcium responses. J Cell Sci 2001, 114:3979-3989.
21. 2+ responses in αT3-1 gonadotropes. J Biol Chem 2001, 276:3123-3129.
22. Wojcikiewicz RJH, Xu Q, Webster JM, Alzayady K, Gao C. Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1, 4, 5 trisphosphate receptors in αT3-1 anterior pituitary cells. J Biol Chem 2003, 278:940-947.
23. Sliter D, Aguiar M, Gygi SP, Wojcikiewicz RJH. Activated inositol 1, 4, 5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation. J Biol Chem 2011, 286: 1074-1082.
24. Lee B, Gai W, Laychock SG. Proteasomal activation mediates down-regulation of inositol 1, 4, 5-trisphosphate receptor and calcium mobilization in rat pancreatic islets. Endocrinology 2001, 142:1744-1751.
25. Wojcikiewicz RJH, Ernst SA, Yule DI. Secretagogues cause the ubiquitination and down-regulation of inositol 1, 4, 5 trisphosphate receptors in rat pancreatic acinar cells. Gastroenterology 1999, 116:1194-1201.
26. Parrington J, Brind S, De Smedt H, Gangeswaran R, Lai AF, Wojcikiewicz R, Carroll J. Expression of inositol 1, 4, 5 trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and down-regulated after fertilization. Dev Biol 1998, 203:451-461.
27. Jellerette T, He CL, Wu H, Parys JB, Fissore RA. Down-regulation of the inositol 1, 4, 5-trisphosphate receptor in mouse eggs following fertilization or parthenogenetic activation. Dev Biol 2000, 223:238-250.
28. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 2005, 85:201-279.
29. Ward JB, Petersen OH, Jenkins SA, Sutton R. Is an elevated concentration of acinar cytosolic free ionized calcium the trigger for acute pancreatitis? Lancet 1995, 346:1016-1019.
30. Pusl T, Nathanson MH. The role of inositol 1, 4, 5-trisphosphate receptors in the regulation of bile secretion in health and disease. Biochem Biophys Res Commun 2004, 322:1318-1325.
31. Rong YP, Distelhorst CW. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol 2008, 70: 73-91.
32. Oberdorf JA, Webster JM, Zhu CC, Luo SG, Wojcikiewicz RJH. Down-regulation of types I, II and III inositol 1, 4, 5 trisphosphate receptors is mediated by the ubiquitin / proteasome pathway. Biochem J 1999, 339:453-461.
33. Schwartz AL, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 2009, 49:73-96.
34. Vembar SS, Brodsky JL. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 2008, 9:944-957.
35. Hegde RS, Ploegh HL. Quality and quantity control at the endoplasmic reticulum. Curr Opin Cell Biol 2010, 22:437-446.
36. Carvalho P, Goder V, Rapoport T. Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 2006, 126: 361-373.
37. Komander D. The emerging complexity of protein ubiquitination. Biochem Soc Trans 2009, 37:937-953.
38. Deshaies RJ, Joazeiro CAP. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009, 78:399-434.
39. Ravid T, Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol 2008, 9:679-689.
40. Catic A, Collins C, Church GM, Ploegh HL. Preferred in vivo ubiquitination sites. Bioinformatics 2004, 20:3302-3307.
41. Hampton RY, Garza RM. Protein quality control as a strategy for cellular regulation: lessons from ubiquitin-mediated regulation of the sterol pathway. Chem Rev 2009, 109:1561-1574.
42. Brodsky JL, Wojcikiewicz RJH. Substrate-specific mediators of ER associated degradation (ERAD). Curr Opin Cell Biol 2009, 21:516-521.
43. Neutzner A, Neutzner M, Benischke A-S, Ryu S-W, Frank S, Youle RJ, Karbowski M. A systematic search for ER membrane-associated RING finger proteins identifies nixin/ZNRF4 as a regulator of calnexin stability and ER homeostatis. J Biol Chem 2011, 286: 8633-8643.
44. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009, 78:477-513.
45. 2+. J Biol Chem 2003, 278: 38238-38246.
46. Alzayady KJ, Panning MM, Kelley GG, Wojcikiewicz RJH. Involvement of the p97-Ufd1-Npl4 complex in the regulated endoplasmic reticulum-associated degradation of inositol 1, 4, 5-trisphosphate receptors. J Biol Chem 2005, 280:34530-34537.
47. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D, Gygi SP. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 2003, 21:921-926.
48. Kirkpatrick DS, Denison C, Gygi SP. Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteaomics. Nat Cell Biol 2005, 7:750-757.
49. Kirkpatrick DS, Hathaway NA, Hanna J, Elsasser S, Rush J, Finley D, King RW, Gygi SP. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat Cell Biol 2006, 8:700-710.
50. Sliter D, Kirkpatrick DS, Alzayady K, Kubota K, Gygi SP, Wojcikiewicz RJ. Mass spectral analysis of type I inositol 1, 4, 5-trisphosphate receptor ubiquitination. J Biol Chem 2008, 283:35319-35328.
51. Browman DT, Hoegg MB, Robbins SM. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol 2007, 17:394-402.
52. Pearce MMP, Wormer DB, Wilkens S, Wojcikiewicz RJH. An endoplasmic reticulum (ER) membrane complex composed of SPFH1 and SPFH2 mediates the ER-associated degradation of inositol 1, 4, 5-trisphosphate receptors. J Biol Chem 2009, 284: 10433-10445.
53. 3 receptors and other substrates in mammalian cells. J Biol Chem 2007, 282:20104-20115.
54. Lu JP, Wang Y, Sliter DA, Pearce MMP, Wojcikiewicz RJH. RNF170, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1, 4, 5-trisphosphate receptor ubiquitination and degradation. J Biol Chem 2011, 286:24426-24433.
55. Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, Mikoshiba K. Subtype-specific and ER lumenal environment-dependent regulation of inositol 1, 4, 5-trisphosphate receptor type 1 by ERp44. Cell 2005, 120:85-98.
56. Kang J, Kang S, Yoo SH, Park S. Identification of residues participating in the interaction between an intraluminal loop of inositol 1, 4, 5-trisphosphate receptor and a conserved N-terminal region of chromogranin B. Biochim Biophys Acta 2007, 1774:503-509.
57. English AR, Zurek N, Voeltz GK. Peripheral ER structure and function. Curr Opin Cell Biol 2009, 21:1-7.
58. 2+ store. Commun Integr Biol 2010, 3:462-464.
59. Hamasaki M, Yoshimori T. Where do they come from? Insights into autophagosome formation. FEBS Lett 2010, 584:1296-1301.
60. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005, 115:2665-2672.
61. Hirota J, Furuichi T, Mikoshiba K. Inositol 1, 4, 5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J Biol Chem 1999, 274: 34433-34437.
62. Assefa Z, Bultynck G, Szlufcik K, Nadif Kasri N, Vermassen E, Goris J, Missiaen L, Callewaert G, Parys JB, De Smedt H. Caspase-3-induced truncation of type 1 inositol trisphosphate receptor type 1 accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis. J Biol Chem 2004, 279:43227-43236.
63. 2+ signalling. Biol Cell 2008, 100:39-49.